Clinical Neuropharmacology · 2010 · 23 citations · 15 references
PharmacyPharmacologyPharmacotherapyHepatologyHepatotoxicologyNeurotoxicologyHepatic NecrosisHepatic ToxicityHepatotoxicity MechanismsLiver DiseaseCausal HypothesesClinical Diagnosis Of HepatotoxicityCorticosteroid-induced Liver InjuryDemyelinating Disease PathologyEnzymesHigh-dose MethylprednisoloneMethylprednisolone UseSerial Monitoring Of Liver Enzymes
Liver toxicity, although not mentioned among the possible adverse effects of corticosteroids, has been occasionally reported in literature. We observed 2 cases of hepatotoxicity after a high-dose methylprednisolone treatment of a demyelinating disease and evaluated the potential relationship in the light of available evidence. The first patient developed a histologically documented acute hepatitis and recovered after 3 weeks. In the second patient, a mild augmentation of liver enzymes occurred, followed by normalization in a few days. The causal relationship between hepatotoxicity and methylprednisolone treatment was deemed probable in both cases. Careful review of the literature suggests that corticosteroid-induced liver damage may be more frequent than commonly believed.
15
A method for estimating the probability of adverse drug reactions
C. A. Naranjo, U. Busto, Edward M. Sellers et al. · Clinical Pharmacology & Therapeutics · 1981 · 11.6K citations
Methylprednisolone-Induced Toxic Hepatitis
Firdevs Topal, Ersan Özaslan, Sabiye Akbulut et al. · Annals of Pharmacotherapy · 2006 · 49 citations
Protein expression analysis of drug-mediated hepatotoxicity in the Sprague-Dawley rat
Wai J. Man, Ian R. White, Duncan Bryant et al. · PROTEOMICS · 2002 · 38 citations